Search for NTRK1 proto-oncogene rearrangements in human thyroid tumours originated after therapeutic radiation

British Journal of Cancer

Volumn 82, Issue 2, 2000, Pages 308-314

  Bounacer, A ^a   Schlumberger, M ^b   Wicker, R ^a   Du Villard, J A ^a   Caillou, B ^b   Sarasin, A ^a   Suarez H G ^a  

^a CNRS   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Ionizing radiation; NTRK1 proto oncogene; Rearrangements; Thyroid; TRK oncogene

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER RADIOTHERAPY; CHILD; CLINICAL ARTICLE; FEMALE; GENE REARRANGEMENT; HUMAN; LYMPH NODE METASTASIS; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SOUTHERN BLOTTING; THYROID ADENOMA; THYROID PAPILLARY CARCINOMA;

EID: 0033954244     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.0920     Document Type: Article

References (39)

1. Beimfohr C, Klugbauer S, Demidchick E, Lengfelder E and Raber HM (1999) NTRKI re-arrangement in papillary thyroid carcinomas of children after the Chernobyl reactor accident. Int J Cancer 80: 842-847
2. Bongarzone I, Pierotti M, Monzini N, Mondellini P, Manenti G, Donghi R, Pilotti S, Grieco M, Santoro M, Fusco A, Vecchio G and Della-Porta G (1989) High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma. Oncogene 4: 1457-1462
3. Bongarzone I, Fugazzola L, Vigneri P, Mariani L, Mondellini P, Pacini F, Basolo F, Pinchera A, Pilotti S and Pierotti MA (1996) Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRKI in papillary thyroid carcinoma. J. Clin Endocrinol Metab 81: 2006-2009
4. Bounacer A, Wicker R, Caillou B, Cailleux AF, Sarasin A, Schlumberger M and Suárez HG (1997) High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation. Oncogene 15: 1263-1273
5. Butti MG, Bongarzone I, Ferraresi G, Mondellini P, Borrello MG and Pierotti MA (1993) A sequence analysis of the genomic regions involved in the rearrangements between TPM3 and NTRKI genes producing TRK oncogenes in papillary thyroid carcinomas. Genomics 28: 15-24
6. Challeton C, Bounacer A, Du Villard JA, Caillou B, De Vathaire F. Monier R, Schlumberger M and Suárez HG (1995) Pattern of ras and gsp oncogene mutations in radiation-associated human thyroid tumors. Oncogene 11: 601-603
7. Challeton C, Branea F, Schlumberger M, Gaillard N, de Vathaire F, Badie C, Antonini P and Parmentier C (1997) Characterization and radiosensitivity at high or low dose rate of four cell lines derived from human thyroid tumors. Int J Radiat Oncol Biol Phys 37: 163-169
8. Conrad RA, Dobyns BM and Sutow WW (1970) Thyroid-neoplasia as late effect of exposure to radioactive iodine in fallout. JAMA 214: 316-324
9. Delvincourt C, Patey M, Flament JB, Suarez HG, Larbre H, Jardillier JC and Delisle MJ (1996) Ret and trk proto-oncogene activation in thyroid papillary carcinomas in French patients from the Champagene-Ardenne region. Clin Biochem 29: 267-271
10. Diallo I, Lamon A, Shamsaldin A, Grimaud E, De Vathaire F and Chavaudra J (1996) Estimation of the radiation dose delivered to any point outside the target volume per patient treated with external beam radiotherapy. Radiother Oncol 38: 269-271
11. Duffy BJJ and Fitzgerald PJ (1950) Cancer of the thyroid in children: a report of 28 cases. J Clin Endocrinol Metab 10: 1296-1308
12. Fogelfeld L, Bauer TK, Schneider AB, Swartz JE and Zitman R (1996) p53 gene mutations in radiation-induced thyroid cancer. J Clin Endocrinol Metab 81: 3039-3044
13. Fugazzola L, Pilotti S, Pinchera A, Vorontsova TV, Mondellini P, Bongarzone I, Greco A, Astakhova L, Butti MG, Demidchik EP, Pacini F and Pierotti MA (1995) Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident. Cancer Res 55: 5617-5620
14. Greco A, Pierotti MA, Bongarzone I, Pagliardini I, Lanzi C and Della-Porta G (1992) Trk-T1 is a novel oncogene formed by the fusion of tpr and trk genes in human papillary thyroid carcinomas. Oncogene 7: 237-242
15. Greco A, Mariani C, Miranda C, Lupas A, Pagliardini S, Pomati M and Pierotti MA (1995)The DNA rearrangement that generates the TRK T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain. Mol Cell Biol 15: 6118-6127
16. Hedinger C, Williams ED and Sobin LH (1989) The WHO histologic classification of thyroid tumours: a commentary on the second edition. Cancer 63: 908-911
17. Ito T, Seyama T, Iwamoto KS, Mizuno T, Tronko ND, Komissarenko IV, Cherstovoy ED, Satow Y, Takeichi N, Dohi K and Akiyama M (1994) Activated Ret oncogene in thyroid cancers of children from areas contamined by Chernobyl accident. Lancet 344: 259
18. Kaplan DR, Hempstead BL, Martin-Zanca D, Chao MV and Parada LF (1991) The trk proto-oncogene product a signal transducing receptor for nerve growth factor. Science 252: 554-558
19. Kazakov VK, Demidchik EP and Astakhova LN (1992) Thyroid cancer after Chernobyl. Nature 395: 21
20. Klein R, Jing S, Nanduri V, O'Rourke E and Barbacid M (1991) The trk proto-oncogene encodes a receptor for nerve growth factor. Cell 65: 189-197
21. Klugbauer S, Lengfelder E, Demidchik EP and Rabes HM (1995) High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident. Oncogene 11: 2459-2467
22. Martin-Zanca D, Hughes SH and Barbacid M (1986) A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences. Nature 319. 743-748
23. Martin-Zanca D, Oskam R, Mitra G, Copeland T and Barbacid M (1989) Molecular and biochemical characterization of the human TRK proto-oncogene. Mol Cell Biol 9: 24-33
24. Martin-Zanca D, Barbacid M and Parada L (1990) Expression of the trk protooncogene is restricted to the sensory cranial and spinal ganglia of neural crest origin in mouse development. Genes Dev 4: 683-694
25. Michelin S, Daya Grosjean L, Sureau F, Saïd S, Sarasin A and Suárez HG (1993) Characterization of c-met proto-oncogene actived in human xeroderma pigmentosum cells after treatment with N-methyl-N′-nitro-N-nitrosoguanidine (MNNG). Oncogene 8: 1983-1991
26. Nikiforov YE, Nikiforova MN, Gnepp DR and Fagin JA (1996) Prevalence of mutations of ras and p53 in benign and malignant thyroid tumours from children exposed to radiation after Chernobyl nuclear accident. Oncogene 13: 687-693
27. Nikiforov YE, Rowland JM, Bove KE, Monforte-Muñoz H and Fagin J (1997) Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res 57: 1690-1694
28. Park M, Dean M, Cooper CS, Schmidt M, O'Brien SJ, Blair DG and Van de Woude GF (1986) Mechanisms of met oncogene activation. Cell 45: 895-904
29. Roth D, Lindahl T and Gellert M (1995) Repair and recombination. How to make ends meet. Curr Biol 5: 496-499
30. Said S, Schlumberger M and Suárez HG (1994) Oncogenes and anti-oncogenes in human epithelial thyroid tumours. J Endocrinol Invest 17: 371-379
31. Sanger F, Nicklen S and Coulson AR (1977) DNA sequencing with chain terminating inhibition. Proc Natl Acad Sci USA 82. 488-492
32. Santoro M, Melillo RM, Grieco M, Berlingieri MT, Vecchio G and Fusco A (1993) The TRK and RET tyrosine kinase oncogenes cooperate with ras in the neoplastic transformation of a rat thyroid epithelial cell line. Cell Growth Differ 4: 77-84
33. Shore RE, Woodard E, Hildreth N, Dvoresky P, Hempelmann L and Pasternack B (1985) Thyroid tumours following thymus irradiation. J Natl Cancer Inst 74: 1177-1184
34. Suárez HG, Du Villard JA, Severino M, Caillou B, Schlumberger M, Tubiana M, Parmentier C and Monier R (1990) Presence of mutations in all three ras genes in thyroid tumors. Oncogene 5: 565-570
35. Suárez HG, Du Villard JA, Caillou B, Schlumberger M, Parmentier C and Monier R (1991) Gsp mutations in human thyroid tumours. Oncogene 6: 677-679
36. Viglietto G, Chiappetta G, Martinez-Tello FJ, Fukunaga FH, Tallini G, Rigopoulou D, Visconti R, Mastro A, Santoro M and Fusco A (1995) RET/PTC oncogene activation is an early event in thyroid carcinogenesis. Oncogene 11: 1207-1210
37. Wajjwalku W, Nakamura S, Hasegawa Y, Miyazaki K, Satoh Y, Funahashi H, Matsuyama M and Takahashi M (1992) Low frequency of rearrangements of the ret and trk proto-oncogenes in Japanese papillary carcinomas. Jpn J Cancer Res 83: 671-675
38. Weier H-UG, Rhein AP, Shadravan F, Collins C and Polikoff D (1995) Rapid physical mapping of the human trk protooncogene (NTRKI) to human chromosome 1q21-q22 hy PI clone selection, fluorescence in situ hybridization (FISH), and computer-assisted microscopy. Genomics 26: 390-393
39. Wright P, Williams ED, Lemoine NR and Wynford-Thomas D (1991) Radiation associated and 'spontaneous' human thyroid carcinomas show different pattern of ras oncogene mutation. Oncogene 6: 471-473